ICU Medical (ICUI) Tops Q2 EPS by 84c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
ICU Medical, Inc. Announces Second Quarter 2018 Results
August 9, 2018 4:01 PM EDTSAN CLEMENTE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30, 2018.
Second Quarter 2018 Results
Second quarter 2018 revenue was $360.5 million, compared to $331.5 million in the same period last year. GAAP gross profit for the second quarter of 2018 was $151.8 million, as compared to $88.1 million in the same period last year. GAAP gross margin for the second quarter of... More
